Skip to main content
Erschienen in: Acta Neurochirurgica 4/2021

03.02.2021 | Original Article - Tumor - Schwannoma

Pretreatment ADC predicts tumor control after Gamma Knife radiosurgery in solid vestibular schwannomas

verfasst von: Pranay Soni, Tamia Potter, Matthew Poturalski, Christopher Karakasis, Hamid Borghei-Razavi, Pablo F. Recinos, Varun R. Kshettry, Jonathan Lee

Erschienen in: Acta Neurochirurgica | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Radiosurgery is a well-established treatment for vestibular schwannomas (VSs), but it is often difficult to identify which tumors will respond to treatment. We sought to determine whether pretreatment or posttreatment tumor apparent diffusion coefficient (ADC) values could predict tumor control in patients undergoing Gamma Knife radiosurgery (GKRS) and whether these values could differentiate between cases of pseudoprogression and cases of true progression in the early posttreatment period.

Methods

We retrospectively identified patients who underwent GKRS for solid VSs between June 2008 and November 2016 and who had a minimum follow-up of 36 months. Pretreatment and posttreatment minimum, mean, and maximum ADC values were measured for the whole tumor volume and were compared between patients with tumor control and those with tumor progression. In patients with early posttreatment tumor enlargement, ADC values were compared between patients with pseudoprogression and those with true progression.

Results

Of the 44 study patients, 34 (77.3%) demonstrated tumor control at final follow-up. Patients with tumor control had higher pretreatment minimum (1.35 vs 1.09; p = 0.008), mean (1.80 vs 1.45; p = 0.004), and maximum (2.41 vs 1.91; p = 0.011) ADC values than patients with tumor progression. ADC values did not differ between patients with pseudoprogression and those with true progression at early posttreatment follow-up.

Conclusions

ADC values may be helpful in predicting response to GKRS in patients with solid VSs but cannot predict which tumors will undergo pseudoprogression. Patients with higher pretreatment ADC values may be more likely to demonstrate posttreatment tumor control.
Literatur
1.
Zurück zum Zitat Boari N et al (2014) Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients. J Neurosurg 121(Suppl):123–142CrossRef Boari N et al (2014) Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients. J Neurosurg 121(Suppl):123–142CrossRef
2.
Zurück zum Zitat Bowden G et al (2017) Cystic vestibular schwannomas respond best to radiosurgery. Neurosurgery 81(3):490–497CrossRef Bowden G et al (2017) Cystic vestibular schwannomas respond best to radiosurgery. Neurosurgery 81(3):490–497CrossRef
3.
Zurück zum Zitat Camargo A et al (2017) Pretreatment ADC values predict response to radiosurgery in vestibular schwannomas. AJNR Am J Neuroradiol 38(6):1200–1205CrossRef Camargo A et al (2017) Pretreatment ADC values predict response to radiosurgery in vestibular schwannomas. AJNR Am J Neuroradiol 38(6):1200–1205CrossRef
4.
Zurück zum Zitat Chuang CC et al (2012) Use of apparent diffusion coefficients in evaluating the response of vestibular schwannomas to Gamma Knife surgery. J Neurosurg 117(Suppl):63–68CrossRef Chuang CC et al (2012) Use of apparent diffusion coefficients in evaluating the response of vestibular schwannomas to Gamma Knife surgery. J Neurosurg 117(Suppl):63–68CrossRef
5.
Zurück zum Zitat Elson A et al (2015) Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma. J Neurooncol 122(3):549–558CrossRef Elson A et al (2015) Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma. J Neurooncol 122(3):549–558CrossRef
6.
Zurück zum Zitat Frisch CD et al (2017) Stereotactic radiosurgery for cystic vestibular schwannomas. Neurosurgery 80(1):112–118CrossRef Frisch CD et al (2017) Stereotactic radiosurgery for cystic vestibular schwannomas. Neurosurgery 80(1):112–118CrossRef
7.
Zurück zum Zitat Guo AC et al (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224(1):177–183CrossRef Guo AC et al (2002) Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 224(1):177–183CrossRef
8.
Zurück zum Zitat Hayhurst C, Zadeh G (2012) Tumor pseudoprogression following radiosurgery for vestibular schwannoma. Neuro Oncol 14(1):87–92CrossRef Hayhurst C, Zadeh G (2012) Tumor pseudoprogression following radiosurgery for vestibular schwannoma. Neuro Oncol 14(1):87–92CrossRef
9.
Zurück zum Zitat Huang CF et al (2010) Apparent diffusion coefficients for evaluation of the response of brain tumors treated by Gamma Knife surgery. J Neurosurg 113(Suppl):97–104CrossRef Huang CF et al (2010) Apparent diffusion coefficients for evaluation of the response of brain tumors treated by Gamma Knife surgery. J Neurosurg 113(Suppl):97–104CrossRef
10.
Zurück zum Zitat Johnson S et al (2019) Long term results of primary radiosurgery for vestibular schwannomas. J Neurooncol 145(2):247–255CrossRef Johnson S et al (2019) Long term results of primary radiosurgery for vestibular schwannomas. J Neurooncol 145(2):247–255CrossRef
11.
Zurück zum Zitat Khattab MH et al (2020) Longitudinal radiographic outcomes of vestibular schwannoma in single and fractionated stereotactic radiosurgery: a retrospective cohort study. J Neurol Surg B Skull Base 81(3):308–316CrossRef Khattab MH et al (2020) Longitudinal radiographic outcomes of vestibular schwannoma in single and fractionated stereotactic radiosurgery: a retrospective cohort study. J Neurol Surg B Skull Base 81(3):308–316CrossRef
12.
Zurück zum Zitat Kim JH et al (2017) Predictive factors of unfavorable events after gamma knife radiosurgery for vestibular schwannoma. World Neurosurg 107:175–184CrossRef Kim JH et al (2017) Predictive factors of unfavorable events after gamma knife radiosurgery for vestibular schwannoma. World Neurosurg 107:175–184CrossRef
13.
Zurück zum Zitat Klijn S et al (2016) Gamma Knife radiosurgery for vestibular schwannomas: evaluation of tumor control and its predictors in a large patient cohort in The Netherlands. J Neurosurg 124(6):1619–1626CrossRef Klijn S et al (2016) Gamma Knife radiosurgery for vestibular schwannomas: evaluation of tumor control and its predictors in a large patient cohort in The Netherlands. J Neurosurg 124(6):1619–1626CrossRef
14.
Zurück zum Zitat Kshettry VR et al (2015) Incidence of vestibular schwannomas in the United States. J Neurooncol 124(2):223–228CrossRef Kshettry VR et al (2015) Incidence of vestibular schwannomas in the United States. J Neurooncol 124(2):223–228CrossRef
15.
Zurück zum Zitat Mardor Y et al (2004) Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 6(2):136–142CrossRef Mardor Y et al (2004) Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 6(2):136–142CrossRef
16.
Zurück zum Zitat Marston AP et al (2017) Pretreatment growth rate as a predictor of tumor control following Gamma Knife radiosurgery for sporadic vestibular schwannoma. J Neurosurg 127(2):380–387CrossRef Marston AP et al (2017) Pretreatment growth rate as a predictor of tumor control following Gamma Knife radiosurgery for sporadic vestibular schwannoma. J Neurosurg 127(2):380–387CrossRef
17.
Zurück zum Zitat Mindermann T, Schlegel I (2014) How to distinguish tumor growth from transient expansion of vestibular schwannomas following Gamma Knife radiosurgery. Acta Neurochir (Wien) 156(6):1121–1123CrossRef Mindermann T, Schlegel I (2014) How to distinguish tumor growth from transient expansion of vestibular schwannomas following Gamma Knife radiosurgery. Acta Neurochir (Wien) 156(6):1121–1123CrossRef
18.
Zurück zum Zitat Nagano O et al (2008) Transient expansion of vestibular schwannoma following stereotactic radiosurgery. J Neurosurg 109(5):811–816CrossRef Nagano O et al (2008) Transient expansion of vestibular schwannoma following stereotactic radiosurgery. J Neurosurg 109(5):811–816CrossRef
19.
Zurück zum Zitat Ostrom QT et al (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016. Neuro Oncol 21(Suppl 5):v1–v100CrossRef Ostrom QT et al (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016. Neuro Oncol 21(Suppl 5):v1–v100CrossRef
20.
Zurück zum Zitat Plotkin SR et al (2009) Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. J Neurooncol 93(1):61–77CrossRef Plotkin SR et al (2009) Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. J Neurooncol 93(1):61–77CrossRef
21.
Zurück zum Zitat Pollock BE (2006) Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience. Neurosurgery 58(2):241–248 discussion 241-8CrossRef Pollock BE (2006) Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience. Neurosurgery 58(2):241–248 discussion 241-8CrossRef
22.
Zurück zum Zitat Sasaki M et al (2008) Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology 249(2):624–630CrossRef Sasaki M et al (2008) Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology 249(2):624–630CrossRef
23.
Zurück zum Zitat Watanabe S et al (2016) Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation. J Neurosurg 125(Suppl 1):64–72CrossRef Watanabe S et al (2016) Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation. J Neurosurg 125(Suppl 1):64–72CrossRef
24.
Zurück zum Zitat Wu CC et al (2017) Magnetic resonance imaging characteristics and the prediction of outcome of vestibular schwannomas following Gamma Knife radiosurgery. J Neurosurg 127(6):1384–1391CrossRef Wu CC et al (2017) Magnetic resonance imaging characteristics and the prediction of outcome of vestibular schwannomas following Gamma Knife radiosurgery. J Neurosurg 127(6):1384–1391CrossRef
Metadaten
Titel
Pretreatment ADC predicts tumor control after Gamma Knife radiosurgery in solid vestibular schwannomas
verfasst von
Pranay Soni
Tamia Potter
Matthew Poturalski
Christopher Karakasis
Hamid Borghei-Razavi
Pablo F. Recinos
Varun R. Kshettry
Jonathan Lee
Publikationsdatum
03.02.2021
Verlag
Springer Vienna
Erschienen in
Acta Neurochirurgica / Ausgabe 4/2021
Print ISSN: 0001-6268
Elektronische ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-021-04738-x

Weitere Artikel der Ausgabe 4/2021

Acta Neurochirurgica 4/2021 Zur Ausgabe

Letter to the editor - Neurosurgical technique evaluation

Endoscopic microvascular decompression for glossopharyngeal neuralgia

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.